Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01564069 · ClinicalTrials.gov registry record
Intrathecal Therapy for Chronic Non-Cancer Pain: An Analysis of Its Efficacy
A clinical trial, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- 125
- Enrollment target
NCT01564069: Completed study, sponsored by Brigham and Women's Hospital.
NCT01564069 is a clinical trial that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 125 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01564069 has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- 125 participants
- Enrollment target
Study Summary
Our hypothesis is that patients with intrathecal delivery systems for chronic non-cancer pain will report no improvement treatment efficacy when compared to patients with chronic pain managed with oral or systemic opioid therapies. Our secondary hypothesis is that patients with intrathecal delivery systems for chronic non-cancer pain will report no improvement in treatment efficacy when compared to patients with chronic pain who are managed with non-opioid therapies.
Primary Outcome
The primary objective of this study is to evaluate the treatment efficacy of intrathecal infusions for chronic pain and compare this form of therapy to systemic opioid therapy and non-opioid therapy for chronic pain \> 6 months duration.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2009-03-01 |
| Est. Completion | 2013-03-31 |
What the finished NCT01564069 record still lists
NCT01564069 is an observational study that tracks outcomes without assigning an intervention. The registered 125 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01564069 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01564069 about?
NCT01564069 is a clinical study titled "Intrathecal Therapy for Chronic Non-Cancer Pain: An Analysis of Its Efficacy". Our hypothesis is that patients with intrathecal delivery systems for chronic non-cancer pain will report no improvement treatment efficacy when compared to patients with chronic pain managed with oral or systemic opioid therapies. Our secondary hypothesis is that patients with intrathecal delivery ...
What is the current status of trial NCT01564069?
This trial is currently completed. The enrollment target is 125 participants. The study started on 2009-03-01. Estimated completion is 2013-03-31.
Who is sponsoring clinical trial NCT01564069?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02717039 · 125 participants
Pharmacogenomics of Heparin-Induced Thrombocytopenia
- NCT02763033 · 125 participants · Phase 2
Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients
- NCT02793999 · 125 participants
Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
- NCT03003299 · 125 participants · NA
PARTNER 3 Trial - Aortic Valve-in-Valve
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI